SOL-BIOon Raydium CLMMCLMM
- Chain
- Solana
- TVL
- TVL $335.88K
- APR
- 1.8% APR
- 24h Volume
- $5.97K 24h vol
- Fee tier
- 0.25% fee
- Pool address
- 4LuGwek6…EkTm · observed 2026-10-27
Wealthville Score
Verdict AVOID · 60% confidence
new capital
keep position
urgency to leave
The Wealthville Score of 19/100 gives this pool a middling overall assessment, while Enter 10/100, Hold 30/100, and Exit 60/100 produce a live AVOID verdict. The recorded verdict driver is ai_engine=hold, and the pool ranks #1721 of 9963 raydium-clmm pools, placing it above many listed pools but not among the strongest-ranked opportunities. The assessment would weaken if $336K drained, $6K fell further, or fee generation collapsed; it would improve if sustained volume increased without a comparable rise in liquidity and if reliable range and loss data showed efficient fee capture.
Computed 2026-10-27 18:57 UTC from on-chain yield, liquidity-depth, and risk signals. Not financial advice.
Liquidityhelp
lock$335.88K
Total value locked
$5.97K
24h volume
Yieldhelp
trending_up1.8%
advertised APRFee yield, annualized
≈ -1.7%
adjusted · net of IL (est.)
My Position
account_balance_walletAI Verdict
Avoid
WealthVille AI evaluation verdict for this liquidity pool investment opportunity.
Use a monitored, relatively narrow range only if you can rebalance actively, and set an exit review after two consecutive days of 50% lower 24-hour volume than at entry or a material deterioration in 0.02x. If price leaves the range, stop treating the position as fee-producing until it is rebalanced or closed.
syncAI analysis is refreshing in the background
Performance Breakdown
| Metric | 24h / Day | 7d / Week | 30d / Month |
|---|---|---|---|
| Total APR | 1.8% | — | — |
| Fee APR | 1.8% | — | — |
| Volume | $5.97K | — | — |
| Fees Earned | $14.93 | — | — |
Data sourced from Raydium Protocol, Birdeye, and DexScreener. Updated every snapshot cycle.
Efficiency Metrics
ComputedDeterministic efficiency metrics computed from on-chain data for this liquidity pool. All values are calculated directly from pool analytics — not AI-generated.
Pool Rankings
#1 of 5 SOL-BIO pools
by AI Farmer Score
#1047 of 19676 on raydium-clmm
by AI Farmer Score
Top 7% of all Solana pools
overall rank #9052 of 150817
How This Pool Works
Beginner FriendlyThis page provides real-time AI analytics and performance data for the SOL-BIO liquidity pool on Raydium CLMM. Data is sourced from on-chain Solana activity, Birdeye, DexScreener, and CoinGecko.
Providing liquidity here means depositing SOL and BIO into a shared trading pool and receiving a portion of trading fees. Your token mix can change as traders buy one asset from the pool, and the pool's 1.8% return depends mainly on fees because rewards contribute 0.0%.
Pool Analysis
trending_upYield Source Breakdown
The stated yield decomposes into 1.8% from trading fees and 0.0% from rewards, with 99% of yield coming from fees. Reward dependency is not established, and no current reward contribution is recorded, so the APR is primarily dependent on trading activity rather than emissions. With $6K in 24-hour volume against $336K of liquidity, fee generation may remain modest unless turnover increases.
shieldRisk Assessment
A seven-day impermanent-loss reading and tick-in-range history are not available in the supplied data, so recent price-divergence and range-utilization risk cannot be quantified. As a MEMECOIN pool, BIO can experience sharp price moves, thin exit liquidity, and abrupt changes in trading activity relative to SOL. Any future emissions would also be subject to decay, while exiting during a volatility spike can crystallize losses and incur price impact.
tollSOL Context
SOL is the established base asset in this pair and generally has deeper liquidity across Solana than this pool's size indicates. If SOL moves substantially against BIO, the concentrated-liquidity position can accumulate more of the falling asset and less of the rising one, increasing divergence loss relative to simply holding both tokens.
tollBIO Context
BIO is the memecoin-side asset, so its liquidity and price discovery are likely more dependent on this pair and other specific venues than SOL's. A sharp BIO repricing can move the position outside its active range or leave the LP holding disproportionately more BIO after a decline.
lightbulbSimple Explanation
Providing liquidity here means depositing SOL and BIO into a shared trading pool and receiving a portion of trading fees. Your token mix can change as traders buy one asset from the pool, and the pool's 1.8% return depends mainly on fees because rewards contribute 0.0%.
Token Details
Pool Details
- Pool Address
- 4LuGwek6Jv4xpGvsQwZXonmLuRhrpHtmKVs95bN9EkTm
- Protocol
- Raydium CLMM
- Chain
- solana
- Fee Tier
- —
- Pool Type
- Concentrated Liquidity (CLMM)
- Token A
- SOL (So111111…)
- Token B
- BIO (bioJ9JTq…)
- Created
- 4/20/2026
Explore More
Similar Pools — Same Protocol
APR
0%
APR
0%
APR
0%
APR
0%
By Protocol
hubAll raydium-clmm poolsarrow_forwardBlockchain
dnsAll Solana poolsarrow_forwardNon-Custodial
Your funds are never held by WealthVille. All positions are on-chain.
Verified Data Sources
Raydium, Birdeye, DexScreener, CoinGecko, LlamaYield
AI-Powered Analysis
Proprietary scoring model trained on historical Solana DeFi data
⚠️ WealthVille AI analytics are for informational purposes only. APR, TVL, and AI scores are based on historical and real-time data and do not constitute financial advice. DeFi investments carry significant risk including impermanent loss and smart contract risk. Always do your own research.
Frequently Asked Questions
The recorded reward contribution is 0.0%, so current APR is not supported by an active reward stream. If emissions are introduced later, decay would reduce the reward component over time while fee income would still depend on $6K relative to $336K.
The recorded reward contribution is 0.0%, so current APR is not supported by an active reward stream. If emissions are introduced later, decay would reduce the reward component over time while fee income would still depend on $6K relative to $336K.
There is no recorded reward contribution to remove, so the stated yield already consists of 1.8% in fees and 0.0% in rewards. If incentives are added and later expire, the remaining return would depend on trading fees generated by $6K.
There is no recorded reward contribution to remove, so the stated yield already consists of 1.8% in fees and 0.0% in rewards. If incentives are added and later expire, the remaining return would depend on trading fees generated by $6K.
The risk is substantial because BIO can move sharply against SOL, while $336K liquidity may not support large exits without price impact. The pool's 1.8% return is fee-funded, but fees do not automatically offset losses from a large price divergence.
The risk is substantial because BIO can move sharply against SOL, while $336K liquidity may not support large exits without price impact. The pool's 1.8% return is fee-funded, but fees do not automatically offset losses from a large price divergence.
Review an exit when BIO's price leaves your active range, when two consecutive days show a 50% drop in $6K, or when 0.02x deteriorates materially. Also reassess if liquidity drains or the fee component falls below the level needed to compensate for your risk.
Review an exit when BIO's price leaves your active range, when two consecutive days show a 50% drop in $6K, or when 0.02x deteriorates materially. Also reassess if liquidity drains or the fee component falls below the level needed to compensate for your risk.
A reliable break-even period cannot be calculated because recent impermanent-loss history is unavailable. At the stated fee-only rate of 1.8%, a simple no-price-change approximation would be 1 divided by 1.8% years, but actual recovery depends on future volume, rebalancing, and SOL-BIO price divergence.
A reliable break-even period cannot be calculated because recent impermanent-loss history is unavailable. At the stated fee-only rate of 1.8%, a simple no-price-change approximation would be 1 divided by 1.8% years, but actual recovery depends on future volume, rebalancing, and SOL-BIO price divergence.
